Ledger.Open graph →
SEC Form D · filed February 11, 2019

Aldeyra Therapeutics, Inc

Offering
$25.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LEXINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

David L. Mcmullin · Lexington, MAExecJesse I. Treu · Lexington, MADirectorGary J. Phillips · Lexington, MADirectorScott L. Dakers · Grand Cayman, Cayman IslandsDirectorNicholas L. Lane · Road Town, Tortola, British Virgin IslandsDirectorDavid L. Clark · Lexington, MAExecStephen I. Machatha · Lexington, MAExecStephen I. Machatha · Lexington, MAExecBen J. Bronstein · Lexington, MADirectorJoshua Reed · Charleston, MDExecJoshua Reed · Charleston, MDExecJoseph M. Manko, Jr · Philadelphia, PADirectorBradley D. Ginesin · Kent Cliffs, NYExec · DirectorDavid L. Clark · Lexington, MAExecMichael J. Howe · Philadelphia, PAExec · DirectorBen J. Bronstein · Lexington, MADirectorRichard I. Douglas · Lexington, MADirectorNancy Kukacka · SAN FRANCISCO, CADirectorNeal J. Walker · Lexington, MADirectorTodd C. Brady · Lexington, MAExec · DirectorDavid L. Mcmullin · Lexington, MAExecMartin J. Joyce · Lexington, MADirectorJesse I. Treu · Lexington, MADirectorRichard I. Douglas · Lexington, MADirectorMartin J. Joyce · Lexington, MADirectorDavid A. Achey · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗